Stay updated with breaking news from Kosh Agarwal. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
WARMINSTER, Pa., May 22, 2024 -- Arbutus Biopharma Corporation , a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop a functional cure for people with...
End-of-treatment data from two Phase 2a combination clinical trials with imdusiran to be presented at the EASL Congress in June 2024 Preliminary data from the single-dose portion of the AB-101-001...
Imdusiran data will be highlighted in late breaking presentation WARMINSTER, Pa., Oct. 11, 2023 -- Arbutus Biopharma Corporation , a clinical-stage biopharmaceutical company leveraging its...
– Data from multiple ongoing trials evaluating Vir’s two novel HBV therapies continue to demonstrate substantial reductions in hepatitis B surface antigen...
Findings presented at ILC 2022 in London revealed a cure for hepatitis B will not be easily achieved with the drugs currently in development.